Gary Clark: Unfiltered

Coveo's new RAG-as-a-Service for AWS aims to fix AI's 'hallucination' and security issues, unlocking enterprise value and reshaping the cloud AI market.

At ASH 2025, Bristol Myers Squibb didn't just show new drugs; it unveiled a powerful strategy combining cell therapy and protein degradation.

ProMIS Neurosciences' bet on plasma pTau could make Alzheimer's trials faster and cheaper, giving its unique drug PMN310 a critical edge.

Medicus Pharma consolidates its C-suite, naming a dual President/CFO to steer its high-stakes push in oncology, urology, and next-gen vaccines.

Endeavour Silver's massive convertible note offering is a dual play: shedding costly debt while fueling its giant Pitarrilla silver project in Mexico.

TPVG just locked in cheaper, long-term capital. We analyze why this move signals deep confidence in the future of AI and software innovation.

After past stumbles, Merck unveils two new Alzheimer's candidates targeting different pathways, a high-stakes bet signaling a major strategic shift.

In the shadow of giants, a junior miner uses advanced geophysics to de-risk its hunt for a major discovery in the prolific Vicuña District.

Mobix Labs posts a 54% revenue jump and slashes losses, but a volatile stock and aggressive M&A strategy raise questions about its long-term stability.

With robust economics and U.S. government support, a New York mine is set to become a cornerstone of America's critical mineral independence strategy.

Viasat's NexusWave upgrade promises revolutionary speeds, but it's a strategic move against Starlink amid high-stakes satellite deployment challenges.

Saba Capital's fund boasts a high yield, but a closer look reveals nearly 60% of payments are a return of capital. What does this mean for investors?

Rubico Inc. executes a 1-for-30 reverse split to save its Nasdaq listing. Capital Currents dives into whether this is a strategic pivot or a cosmetic fix.

CEA Industries adds SEC and Nasdaq alum Annemarie Tierney to its board, a strategic move to build institutional trust around its $500M+ BNB holdings.

With cash dwindling, Faraday Future hands keys to a soccer star in Dubai, betting its new MPV can finally turn ambition into revenue and investor faith.

The miner's Q3 revenue is a footnote. The real story is the race to complete its Calcatreu project, a bet that could transform the company by early 2026.

G2 Goldfields is spinning off assets into a new company, G3. We dive into why this move could create two distinct, high-value investment stories in Guyana.

G2 Goldfields is spinning off assets into a new company, G3. We dive into why this move could create two distinct, high-value investment stories in Guyana.

GFG Resources unveils impressive drill results at its Aljo project while launching an aggressive hunt for a new discovery in Ontario's legendary gold district.

With its Nasdaq listing on the line after a 90% stock collapse, Singapore's Springview Holdings turns to a risky reverse split. Is this a lifeline or a delay?